Ignite Creation Date:
2024-05-05 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00669370
Status:
UNKNOWN
Last Update Posted:
2008-04-30
First Post:
2008-04-28
Brief Title:
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
Sponsor:
University of Turku
Organization:
University of Turku
Organization Data
Organization:
University of Turku
Class:
OTHER
Study ID:
2005-002484-87
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Turku
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Raija Ristamäki
Old Organization:
Department of Oncology and Radiotherapy Turku University Hospital
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |